A glimpse of hope was offered to blind people this week after U.S. clinical trials showed transplanted stem cells improved the sight of two patients with severe vision problems. The research, which is touted as the first use of embryonic stem cells being …
Colorado resident Christopher Herod, shown on the back row in the middle, is pictured with his wife, mother and two sons. Herod is receiving stem-cell treatment for Type 1 diabetes. The stem cells have their own set of programming for what they’re …
Reporting in The Lancet, researchers write that a preliminary study shows embryonic stem cell therapy in two patients with macular degeneration was safe. Results suggest the patients' vision improved slightly. Dr. Robert Lanza, Chief Scientific Officer of Advanced Cell Technology and co-author of the study, discusses the trial.
POWAY, CA– – Vet-Stem, Inc. today announced that over 8,000 animals have now been treated with Vet-Stem cell therapy.Vet-Stem began providing stem cells to veterinarians in 2004 and has now provided stem …
Regenerative medicine company Juventas Therapeutics is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients. At 12 months, heart failure patients treated with the company’s stem cell therapy showed “significant” improvements in two key measures — a six-minute distance-walking test, as well as the Minnesota Living with Heart Failure [...]
Embryonic stem cell research raises much ethical conflict and debate as many individuals view the use of embryonic cells as murder and morally offensive. While stem cell research is still in its infancy, the potential that exists for the use of stem cells …
(PhysOrg.com) — Stem cells derived from fat have a surprising trick up their sleeves: Encouraged to develop on a stiff surface, they undergo a remarkable transformation toward becoming mature muscle cells. The new research appears in the …
FOURTEEN years ago James Thomson of the University of Wisconsin isolated stem cells from human embryos. It was an exciting moment. The ability of such cells to morph into any other sort of cell suggested that worn-out or damaged tissues might be repaired …
Heart failure is a leading cause of death in Canada. As part of the ongoing IMPACT-CABG clinical trial to treat advanced heart failure, physicians at the Peter Munk Cardiac Centre performed the first cardiac stem cell transplant in Ontario last week using stem cells derived from the patient’s own bone marrow, isolated completely within the operating room, and implanted into the heart at the time of coronary bypass surgery. Researchers hope that stem cell therapy may be developed into a novel treatment for the 50,000 Canadians diagnosed each year with advanced heart failure…
After more than a decade of study, Toronto scientists have begun injecting stem cells directly into a patient’s heart with the hope of fixing muscle damaged by a serious heart attack. So far, two patients — the first in Ontario — have had the …